Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.00 -4.76% 20.00 748,690 16:35:02
Bid Price Offer Price High Price Low Price Open Price
19.50 20.00 21.50 19.47 19.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.03 -11.14 -4.36 49
Last Trade Time Trade Type Trade Size Trade Price Currency
16:39:29 O 10,000 21.195 GBX

Futura Medical (FUM) Latest News

More Futura Medical News
Futura Medical Investors    Futura Medical Takeover Rumours

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
05/3/202120:44FUTURA a winner for 20158,449
01/7/202010:05fum reality29
20/5/202010:49one million4
21/1/201909:54www.bluediamondcondom.com59
02/12/201613:27FUM delivering on sex,pain and rock'n'roll11,414

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-03-05 16:39:3021.2010,0002,119.50O
2021-03-05 16:35:0220.001,904380.80UT
2021-03-05 16:25:1919.70549108.15O
2021-03-05 16:25:1219.8410,0001,984.00O
2021-03-05 16:16:1119.841,008199.99O
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

DateSubject
05/3/2021
08:20
Futura Medical Daily Update: Futura Medical Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 21p.
Futura Medical Plc has a 4 week average price of 13.39p and a 12 week average price of 13p.
The 1 year high share price is 24.50p while the 1 year low share price is currently 7.25p.
There are currently 245,626,926 shares in issue and the average daily traded volume is 2,199,884 shares. The market capitalisation of Futura Medical Plc is £49,125,385.20.
05/3/2021
17:36
mike10101: I am new on this Board but have been building my stake in FUM over the last year/half and watched/waited. I have worked in Pharma for the last 20 years and this deal is a good one for them. The partner takes all the risk, pays the development and marketing and FUM will just provide technical advice and support so no real costs for them. And they take 50%. I expect a licesnsing deal for the US rights to be a bit more typical - so a small upfront, partner pays for the final FDA trial and FUM take double digit tiered royalties. In Europe, I can see them doing a similar JV deal as they can contribute more, This deal will wake up the major pharma players. Remember Ken James is ex GSK. DYOR but this looks like a great pathway for MED3000. And then you get the cannabaloid gel thrown in for nothing.
02/3/2021
15:58
jailbird: J777J, Do you have read your posts from 5 years + ago? You should. You said this when the share price was nearer 30p. Maybe you have been here longer. I remember the same bullishness when at 70p. I have been following this story for over 10 years. It has become a broken record. You must see that? J777J - 15 Mar 2016 - 08:56:35 - 242 of 8389 FUTURA a winner for 2015 - FUM 2016 looks like being the breakthrough year. Certainly feels like a ground floor opportunity to get into some potentially massive growth. Shelf life sorted,erectile gel promising and pain gel equally promising.All very large markets. New partners and commercial launches weeks away.
26/2/2021
16:55
petroc: Love it when jonnybutlerwain-ker calls it wrong! (Which is every week, come to think of it) The share price finished the week higher than it started last week, so the relentless underlying rise continues. Here's a couple of nuggets: "Sub 14p by the close..." Nope. "I must admit, jonny, I thought you was a tad ambitious forecasting a 15% drop today but whatever may happen you'll be mighty close!" Nope, a mere 11%. "13.6 is close enough. Well done Jonny" Nope, 14.6. "Come on 14p !!!!!!" See above. "Short and distort (S&D) refers to an unethical and illegal practice that involves shorting a stock and then spreading rumors in an attempt to drive down its price. S&D traders manipulate stock prices conducting smear campaigns, often online, to drive down the price of the targeted stock."
24/2/2021
12:35
j777j: They appear to be plants that have been hell bent on trying to suppress the share price. Thing is the potential numbers are simple maths and are simply huge. GLA
24/2/2021
10:31
j777j: Or toshiba for tesla. How about muppet instead of Microsoft? 300 million men addressable marketplace £5 a dose 25p to manufacture. Say each geeza does it twice a week and futura get a 20% marketshare. Then say a 15% royalty rate Now let's discount back to wholesale price only for the royalties,that would be £2.17 per dose and 15% means 32p royalties per dose for Futura. So 20% of 300 million men is 60 million men Twice a week brings in 32p a dose for Futura that is £38 million a week in Royalties V Futura current market cap £48 million Annualize that and you get the picture Let's be even more conservative as say men only do it once week,the numbers are still staggeringly high. Even if we go to once a month 60 million men with 32p royalty for Futura equates to £230 million a year to Futura in royalties!!!! That would imply the share price should be many multiple higher See you at 100p and way way beyond. All IMHO this does not constitute financial advice the value of shares may rise and fall etc etc etc
27/1/2021
19:40
thebutler: First of all, an excellent call, jonny, on the share price falling. Very good. I know we've been here several times before with the testing of the 14p offer, but it looks like it will happen before the weekend then it's freefall time. Only 2 months cash left. Not looking good for FUM shareholders.
17/12/2020
05:03
glavey: As requested: Voyeurdaz69 - 16 Dec 2020 - 20:02:05 - 8128 of 8129 "I honestly believe that a company will fund the trials and I have a strong hunch (can't say how I know or why) that something is already in place. The clues are there if you look closely. Also the share price is holding at around the 16p mark. If bad news and dilution was imminent don't you think that the share price would be about half what it is now? Mark this post."
25/10/2020
05:22
glavey: Yes and such a fabulous update from the company. Fantastic news in abundance. Given the market wide rise on Friday I can't understand why FUM share price didn't build on Thursday's gains. But the retrace presents a great buying opportunity. It's amazing that so many are obviously missing out here.
16/10/2020
17:35
petroc: Thanks, jonnybutler! Just when the share price needed a bit of a helping hand, up you pop and magically it rises! You know, if it ever did play out exactly as you predicted time after time, the share price would be in minus figures and FUM would have gone bust by now! That's spooky! Anyway, thanks again for your timely intervention.
29/5/2020
01:34
glavey: BTW Tinman, I'm sorry I forgot to answer this for you: "it’s time for you to admit that you’ve been wrong aswell. No point now trying to back track on your comments. You got it wrong" Why don't you have a look back and you will see that I expressed doubt over FUM as an investment when the share price was being 'promoted' to above 40p into the summer of 2019. The share price sunk as 'promotors' took profit and crashed when the trials failed and the money had run out. A dilutive fundraise followed. I think any reasonable person summing that up would be more likely to think 'you got it right' rather than 'you got it wrong'. That said I ordinarily don't feel it necessary to defend my views - I'm happy to let the overall market determine that. Going forward things to be considered now are a) why it took until the trial failure (co-inciding with a need for additional funding) for FUM to 'discover' the placibo gel has 'magical' effects, b) why they suggest it is used in conjunction with other proven, readily available medications when it had previously been argued MED whatever should replace them, c) why one large stockholder, post trial failure, desired not only to absorb a significant placing but also underwrite a retail offering, d) why the share price did not fall in Feb/Mar at a time when just about all other stocks did, e) why it is rising now. Finally, why did Blue Diamond fail to sell if it contained the magic ingredient?
Futura Medical share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210306 06:08:23